Varian Medical Systems Receives SFDA Clearance to Market the UNIQUE Radiotherapy System in China

Varian Medical Systems, Inc. VAR, the world's leading manufacturer of medical technology for treating cancer with radiotherapy, announced today that China's State Food and Drug Administration (SFDA) has granted clearance to market the UNIQUE™ medical linear accelerator, a single-energy machine for treating cancer with advanced forms of image-guided radiotherapy. The versatile UNIQUE system can be used to deliver intensity-modulated radiotherapy (IMRT) and RapidArc® treatments, which precisely target tumors while minimizing exposure of surrounding healthy tissues.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsFDAGlobal
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!